Your Search Returned 1 tagged news report
French last year steered Sirna Therapeutics to a $1.1 billion sale to Merck...Quay, at Nastech's helm for eight years, will become chief scientific officer and remain chairman. RNA interference, the same type of products that spurred the acquisition of...